79 related articles for article (PubMed ID: 7760880)
21. Daunorubicin, cytarabine and fludarabine (DAF) for remission induction in relapsed or refractory acute myeloid leukemia. Evaluation of safety, tolerance and early outcome--Polish Adult Leukemia Group (PALG) pilot study.
Hołowiecki J; Grosicki S; Kyrcz-Krzemien S; Skotnicki AB; Piatkowska-Jakubas B; Warzocha K; Seferynska I; Zdziarska B
Ann Hematol; 2008 May; 87(5):361-7. PubMed ID: 18074133
[TBL] [Abstract][Full Text] [Related]
22. Outcome assessment of age group-specific (+/- 50 years) post-remission consolidation with high-dose cytarabine or bone marrow autograft for adult acute myelogenous leukemia.
Bassan R; Raimondi R; Lerede T; D'emilio A; Buelli M; Borleri G; Personeni A; Bellavita P; Rodeghiero F; Barbui T
Haematologica; 1998 Jul; 83(7):627-35. PubMed ID: 9718868
[TBL] [Abstract][Full Text] [Related]
23. Response in acute myeloid leukemia.
Estey E
Clin Adv Hematol Oncol; 2008 Feb; 6(2):113-7. PubMed ID: 18347562
[TBL] [Abstract][Full Text] [Related]
24. Graft clonogenicity and intensity of pre-treatment: factors affecting outcome of autologous peripheral hematopoietic cell transplantation in patients with acute myeloid leukemia in first remission.
Strodtbeck D; Bornhäuser M; Hänel M; Lerche L; Schaich M; Illmer T; Thiede C; Geissler G; Herbst R; Ehninger G; Platzbecker U
Bone Marrow Transplant; 2005 Dec; 36(12):1083-8. PubMed ID: 16247435
[TBL] [Abstract][Full Text] [Related]
25. FLAIE (fludarabine, cytarabine, idarubicin, and etoposide), a four drug induction chemotherapy for adult acute myeloid leukemia: A single center experience.
Candoni A; Simeone E; Tiribelli M; Malagola M; Russo D; Fanin R
Am J Hematol; 2009 Oct; 84(10):690-2. PubMed ID: 19731308
[No Abstract] [Full Text] [Related]
26. Timed sequential induction chemotherapy and risk-adapted postremission therapy for acute myelogenous leukemia.
Kalaycio M; Advani A; Pohlman B; Sekeres M; Tripp B; Rybicki L; Sobecks R
Am J Hematol; 2008 Nov; 83(11):831-4. PubMed ID: 18756545
[TBL] [Abstract][Full Text] [Related]
27. [Bone marrow transplantation versus maintenance chemotherapy for adult acute leukemia in first remission].
Suzuki R; Iida H; Taji H; Murata M; Sugihara T; Minami S; Kodera Y
Rinsho Ketsueki; 1996 Dec; 37(12):1362-70. PubMed ID: 8997123
[TBL] [Abstract][Full Text] [Related]
28. Histamine dihydrochloride and interleukin-2 in acute myeloid leukemia--background and results.
Brune M; Romero AI; Hellstrand K
Inflamm Res; 2009 Apr; 58 Suppl 1():4-8. PubMed ID: 19271134
[No Abstract] [Full Text] [Related]
29. Treatment for adult acute myeloid leukemia: where we stand in 1995.
Wiernik PH
Acta Haematol Pol; 1995; 26(3):231-7. PubMed ID: 8525767
[No Abstract] [Full Text] [Related]
30. Outcomes of adults with acute myelogenous leukemia in remission given 550 cGy of single-exposure total body irradiation, cyclophosphamide, and unrelated donor bone marrow transplants.
Hallemeier C; Girgis M; Blum W; Brown R; Khoury H; Goodnough LT; Vij R; Devine S; Wehde M; Postma S; Lin HS; Dipersio J; Adkins D
Biol Blood Marrow Transplant; 2004 May; 10(5):310-9. PubMed ID: 15111930
[TBL] [Abstract][Full Text] [Related]
31. NCCN Practice Guidelines for Acute Myelogenous Leukemia.
Appelbaum FR; Baer MR; Carabasi MH; Coutre SE; Erba HP; Estey E; Glenn MJ; Kraut EH; Maslak P; Millenson M; Miller CB; Saba HI; Stone R; Tallman MS;
Oncology (Williston Park); 2000 Nov; 14(11A):53-61. PubMed ID: 11195419
[No Abstract] [Full Text] [Related]
32. The outcome of sibling and unrelated donor allogeneic stem cell transplantation in adult patients with acute myeloid leukemia in first remission who were initially refractory to first induction chemotherapy.
Cook G; Clark RE; Crawley C; Mackinnon S; Russell N; Thomson K; Pearce RM; Towlson K; Marks DI
Biol Blood Marrow Transplant; 2006 Mar; 12(3):293-300. PubMed ID: 16503498
[TBL] [Abstract][Full Text] [Related]
33. Sequential standard dose mitoxantrone and cytosine arabinoside for newly diagnosed adult acute myeloblastic leukemia.
Al Bahar S; Pandita R; Bavishi K; Savani B
Neoplasma; 1999; 46(1):61-5. PubMed ID: 10355536
[TBL] [Abstract][Full Text] [Related]
34. Allogeneic stem cell transplantation in acute myeloid leukemia: a risk-adapted approach.
Lodewyck T; Cornelissen JJ
Blood Rev; 2008 Nov; 22(6):293-302. PubMed ID: 18455284
[TBL] [Abstract][Full Text] [Related]
35. Chemotherapy of acute myeloblastic leukaemia with DAM regimen.
Yunus AB; Sayeed MA; Barua A; Rahman J; Rashid MA
Bangladesh Med Res Counc Bull; 1997 Dec; 23(3):82-6. PubMed ID: 9621477
[TBL] [Abstract][Full Text] [Related]
36. [Treatment of acute leukemia with allogeneic stem cell transplantation].
Seiwerth RS; Mrsić M; Nemet D; Bogdanić V; Mikulić M; Sertić D; Grković L; Cecuk E; Bojanić I; Batinić D; Labar B
Acta Med Croatica; 2009 Jun; 63(3):205-8. PubMed ID: 19827346
[TBL] [Abstract][Full Text] [Related]
37. Is there a role for postremission therapy in older adults with acute myelogenous leukemia (AML)?
Rowe JM
Leukemia; 2005 Aug; 19(8):1324-7. PubMed ID: 15944718
[No Abstract] [Full Text] [Related]
38. [Nursing of a patient with acute myelocytic leukemia during induction of remission].
Asada K
Kurinikaru Sutadi; 1988 Aug; 9(9):880-5. PubMed ID: 3205034
[No Abstract] [Full Text] [Related]
39. Personalized medicine for acute myelogenous leukemia--at the entrance gate.
Swords RT; Dezube BJ; Medeiros BC
Am J Hematol; 2011 Aug; 86(8):631-2. PubMed ID: 21761430
[No Abstract] [Full Text] [Related]
40. Medicine and me.
Abram MB
Conn Med; 1981 Mar; 45(3):163-6. PubMed ID: 6940688
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]
